Home testing devices could increase the number of people diagnosed with sleep condition
Five home-testing devices to diagnose a silent sleep condition seriously harming the health of an estimated 2.5 million adults have been recommended by NICE in draft guidance.
-
Tests could lead to fewer people having unnecessary chemotherapy after surgery for early breast cancer
More people with early breast cancer could be spared chemotherapy and therefore avoid the side effects associated with the treatment after tumour profiling tests were recommended by NICE.
-
Improved deal signals NICE recommendation of sickle cell treatment voxelotor
Around 4,000 people with sickle cell disease could benefit from a new treatment recommended by NICE in final draft guidance.
-
Children and teenagers with an aggressive form of brain cancer set to benefit after NICE recommends new life-extending drug combination treatment
Dabrafenib with trametinib is a targeted treatment that can be taken at home rather than hospital and improves the length and quality of life for patients.
